Cancer survivors fear lymphedema. ImpediMed’s campaigning for testing that can prevent itnews2021-10-05T21:29:42+00:00October 5th, 2021|Fierce Pharma|
Biohaven’s Nurtec, with dual migraine approvals, hits $136M in quarterly sales and leads the pack in market sharenews2021-10-05T14:36:25+00:00October 5th, 2021|Fierce Pharma|
GlaxoSmithKline relocates U.S. operations in Philadelphia, North Carolina as COVID-19 cuts its office space needsnews2021-10-05T14:34:10+00:00October 5th, 2021|Fierce Pharma|
GlaxoSmithKline relocates US operations in Philadelphia, North Carolina as COVID-19 cuts its office space needsnews2021-10-05T14:34:10+00:00October 5th, 2021|Fierce Pharma|
Bayer pledges $464M to upgrade, build production facilities in contraceptives pushnews2021-10-05T13:45:39+00:00October 5th, 2021|Fierce Pharma|
As Revance nears a potential launch for its Botox rival, AbbVie sues for patent infringementnews2021-10-05T13:32:53+00:00October 5th, 2021|Fierce Pharma|
Cambrex to pump $30M into expanding North Carolina manufacturing sitenews2021-10-05T12:40:18+00:00October 5th, 2021|Fierce Pharma|
Merck and Ridgeback’s molnupiravir will be ‘complementary, but not a competitor’ to COVID-19 vaccines: analystnews2021-10-05T11:45:22+00:00October 5th, 2021|Fierce Pharma|
Gates Foundation backs Nanoform’s work to improve drug accessnews2021-10-05T08:51:05+00:00October 5th, 2021|Fierce Pharma|
Syros starts study to drive IV to oral switch in leukemianews2021-10-05T08:47:48+00:00October 5th, 2021|Fierce Pharma|
